Sun Jun-Wei, Zhang Ping-Ping, Ren He, Hao Ji-Hui
Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Hepatobiliary Pancreat Dis Int. 2014 Aug;13(4):428-34. doi: 10.1016/s1499-3872(14)60046-1.
There is an increasing frequency of pancreaticoduodenectomy (PD) and PD with superior mesenteric-portal vein (SMPV) resection in elderly cancer patients. The study aimed to investigate the safety and the survival benefits of PD and PD with SMPV resection in patients under or over 70 years of age.
We divided 296 patients who had undergone PD and PD with SMPV resection into two groups according to their ages: under or over 70 years old. The clinical data were compared between the two groups.
Preoperative comorbidity rate was higher in elder patients than in younger patients (P=0.001). The elder patients were more likely to have postoperative complications (P=0.003). Specifically, complications above grade III were more likely to occur in the elderly patients (P=0.030). Multivariable analysis showed that age (adjusted OR=2.557, P=0.015) and hypertension (adjusted OR=2.443, P=0.019) were independent predictors of postoperative complications. There was no significant difference in the mortality rates between the two groups (P=0.885). In the PD with SMPV resection series, elderly patients were more likely to have postoperative complications (P=0.063), but this difference was not statistically significant. There was no difference in the survival rate of patients with pancreatic ductal adenocarcinoma between the two groups. Operation type (PD vs PD with SMPV resection) did not affect the survival of patients.
Age affects postoperative complication in patients undergoing either PD or PD with SMPV resection. However, extensive experience and advanced perioperative management lower the complication rate to an acceptable limit. Hence it is safe and worthwhile to perform PD for elderly patients. Because of low numbers in the SMPV subset, we could not conclude whether PD with SMPV resection is feasible in elderly patients.
老年癌症患者中行胰十二指肠切除术(PD)及联合肠系膜上静脉-门静脉(SMPV)切除的胰十二指肠切除术的频率日益增加。本研究旨在探讨70岁及以上和70岁以下患者行PD及联合SMPV切除的安全性和生存获益。
我们将296例行PD及联合SMPV切除的患者按年龄分为两组:70岁及以下和70岁以上。比较两组的临床资料。
老年患者术前合并症发生率高于年轻患者(P = 0.001)。老年患者术后更易发生并发症(P = 0.003)。具体而言,Ⅲ级以上并发症更易在老年患者中发生(P = 0.030)。多因素分析显示年龄(校正OR = 2.557,P = 0.015)和高血压(校正OR = 2.443,P = 0.019)是术后并发症的独立预测因素。两组死亡率无显著差异(P = 0.885)。在联合SMPV切除的PD系列中,老年患者更易发生术后并发症(P = 0.063),但这一差异无统计学意义。两组胰腺导管腺癌患者的生存率无差异。手术方式(PD与联合SMPV切除的PD)不影响患者生存。
年龄影响行PD或联合SMPV切除的患者术后并发症。然而,丰富的经验和先进的围手术期管理可将并发症发生率降低至可接受水平。因此,对老年患者行PD是安全且值得的。由于SMPV亚组病例数较少,我们无法得出联合SMPV切除的PD在老年患者中是否可行的结论。